These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Population pharmacokinetics of fluconazole in critically ill patients receiving extracorporeal membrane oxygenation and continuous renal replacement therapy: an ASAP ECMO study. Novy E; Abdul-Aziz MH; Cheng V; Burrows F; Buscher H; Corley A; Diehl A; Gilder E; Levkovich BJ; McGuinness S; Ordonez J; Parke R; Parker S; Pellegrino V; Reynolds C; Rudham S; Wallis SC; Welch SA; Fraser JF; Shekar K; Roberts JA Antimicrob Agents Chemother; 2024 Jan; 68(1):e0120123. PubMed ID: 38063399 [TBL] [Abstract][Full Text] [Related]
4. Population Pharmacokinetics and Dosing Optimization of Piperacillin-Tazobactam in Critically Ill Patients on Extracorporeal Membrane Oxygenation and the Influence of Concomitant Renal Replacement Therapy. Hahn J; Min KL; Kang S; Yang S; Park MS; Wi J; Chang MJ Microbiol Spectr; 2021 Dec; 9(3):e0063321. PubMed ID: 34937189 [TBL] [Abstract][Full Text] [Related]
5. NONMEM population pharmacokinetics and Monte Carlo dosing simulations of imipenem in critically ill patients with life-threatening severe infections during support with or without extracorporeal membrane oxygenation in an intensive care unit. Jaruratanasirikul S; Boonpeng A; Nawakitrangsan M; Samaeng M Pharmacotherapy; 2021 Jul; 41(7):572-597. PubMed ID: 34080708 [TBL] [Abstract][Full Text] [Related]
6. Population pharmacokinetics and target attainment of ciprofloxacin in critically ill patients. Abdulla A; Rogouti O; Hunfeld NGM; Endeman H; Dijkstra A; van Gelder T; Muller AE; de Winter BCM; Koch BCP Eur J Clin Pharmacol; 2020 Jul; 76(7):957-967. PubMed ID: 32307575 [TBL] [Abstract][Full Text] [Related]
7. Incremental research approach to describing the pharmacokinetics of ciprofloxacin during extracorporeal membrane oxygenation. Sinnah F; Shekar K; Abdul-Aziz MH; Buscher H; Diab SD; Fisquet S; Fung YL; McDonald CI; Reynolds C; Rudham S; Wallis SC; Welch S; Xie J; Fraser JF; Roberts JA; Crit Care Resusc; 2017 Oct; 19(Suppl 1):8-14. PubMed ID: 29084496 [TBL] [Abstract][Full Text] [Related]
8. Population Pharmacokinetics Analysis and Dosing Simulations Of Meropenem in Critically Ill Patients with Pulmonary Infection. Lan J; Wu Z; Wang X; Wang Y; Yao F; Zhao BX; Wang Y; Chen J; Chen C J Pharm Sci; 2022 Jun; 111(6):1833-1842. PubMed ID: 35090867 [TBL] [Abstract][Full Text] [Related]
9. Prospective Cohort Study of Population Pharmacokinetics and Pharmacodynamic Target Attainment of Vancomycin in Adults on Extracorporeal Membrane Oxygenation. Jung Y; Lee DH; Kim HS Antimicrob Agents Chemother; 2021 Jan; 65(2):. PubMed ID: 33257444 [TBL] [Abstract][Full Text] [Related]
10. Population pharmacokinetics of cefepime in critically ill patients receiving extracorporeal membrane oxygenation (an ASAP ECMO study). Cheng V; Abdul-Aziz MH; Burrows F; Buscher H; Corley A; Diehl A; Jakob SM; Levkovich BJ; Pellegrino V; Que YA; Reynolds C; Rudham S; Wallis SC; Welch SA; Zacharias D; Roberts JA; Shekar K; Fraser JF Int J Antimicrob Agents; 2021 Dec; 58(6):106466. PubMed ID: 34688834 [TBL] [Abstract][Full Text] [Related]
11. Population Pharmacokinetics of Meropenem in Critically Ill Korean Patients and Effects of Extracorporeal Membrane Oxygenation. Lee DH; Kim HS; Park S; Kim HI; Lee SH; Kim YK Pharmaceutics; 2021 Nov; 13(11):. PubMed ID: 34834278 [TBL] [Abstract][Full Text] [Related]
12. The population pharmacokinetics and dose optimization of polymyxin B in critically ill patients with or without extracorporeal membrane oxygenation. Ye Q; Wang Q; Chen W; Zhang R; Chen Z; Li P; Zhang X; Zhan Q; Wang C J Clin Pharm Ther; 2022 Oct; 47(10):1608-1618. PubMed ID: 35716048 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and Monte Carlo Dosing Simulations of Imipenem in Critically Ill Patients with Life-Threatening Severe Infections During Support with Extracorporeal Membrane Oxygenation. Jaruratanasirikul S; Vattanavanit V; Wongpoowarak W; Nawakitrangsan M; Samaeng M Eur J Drug Metab Pharmacokinet; 2020 Dec; 45(6):735-747. PubMed ID: 32886347 [TBL] [Abstract][Full Text] [Related]
14. Imipenem Population Pharmacokinetics: Therapeutic Drug Monitoring Data Collected in Critically Ill Patients with or without Extracorporeal Membrane Oxygenation. Chen W; Zhang D; Lian W; Wang X; Du W; Zhang Z; Guo D; Zhang X; Zhan Q; Li P Antimicrob Agents Chemother; 2020 May; 64(6):. PubMed ID: 32253220 [TBL] [Abstract][Full Text] [Related]
15. Population pharmacokinetics of intravenous sufentanil in critically ill patients supported with extracorporeal membrane oxygenation therapy. Hahn J; Yang S; Min KL; Kim D; Jin BH; Park C; Park MS; Wi J; Chang MJ Crit Care; 2019 Jul; 23(1):248. PubMed ID: 31288863 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and Monte Carlo Simulation of Meropenem in Critically Ill Adult Patients Receiving Extracorporeal Membrane Oxygenation. Lee JH; Lee DH; Kim JS; Jung WB; Heo W; Kim YK; Kim SH; No TH; Jo KM; Ko J; Lee HY; Jun KR; Choi HS; Jang JH; Jang HJ Front Pharmacol; 2021; 12():768912. PubMed ID: 34790131 [No Abstract] [Full Text] [Related]
17. Current Ceftriaxone Dose Recommendations are Adequate for Most Critically Ill Children: Results of a Population Pharmacokinetic Modeling and Simulation Study. Hartman SJF; Upadhyay PJ; Hagedoorn NN; Mathôt RAA; Moll HA; van der Flier M; Schreuder MF; Brüggemann RJ; Knibbe CA; de Wildt SN Clin Pharmacokinet; 2021 Oct; 60(10):1361-1372. PubMed ID: 34036552 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and Time above the MIC Exposure of Cefepime in Critically Ill Patients Receiving Extracorporeal Membrane Oxygenation (ECMO). Kois AK; Gluck JA; Nicolau DP; Kuti JL Int J Antimicrob Agents; 2022 Jul; 60(1):106603. PubMed ID: 35577257 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of cefotaxime and desacetylcefotaxime in infants during extracorporeal membrane oxygenation. Ahsman MJ; Wildschut ED; Tibboel D; Mathot RA Antimicrob Agents Chemother; 2010 May; 54(5):1734-41. PubMed ID: 20176908 [TBL] [Abstract][Full Text] [Related]
20. Population pharmacokinetics of piperacillin/tazobactam in critically ill Korean patients and the effects of extracorporeal membrane oxygenation. Kim YK; Kim HS; Park S; Kim HI; Lee SH; Lee DH J Antimicrob Chemother; 2022 Apr; 77(5):1353-1364. PubMed ID: 35224630 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]